Table 1 Predicted antigenic sites and their lengths using Bepipred [29] and IEDB [28] analysis tools
Bepipred analysis | IEDB analysis | ||
|---|---|---|---|
Peptide | Length (aa) | Peptide | Length (aa) |
VRPGNFNQ | 8 | DYKVQLFEKYFKY | 13 |
GNAAIT | 6 | HANCVNCTDDRCVLHCANFNVLFAM | 25 |
DKSAGHPFN | 9 | KTCFGPIVRKIFVDGVPFVVSCGYHYKELGLV | 32 |
SYQEQ | 5 | VSLHRHRLSLK | 11 |
DVDNP | 5 | ADPAMHI | 7 |
YPKCDRA | 7 | SSNAFLDLRTSCFSVAALTTG | 21 |
YYVKPGGTSSGDATTAY | 17 | YDFVVSKG | 8 |
SVTLKHFFFA | 10 | ||
DYNYYSYN | 8 | ||
PTMCDIKQMLFCMEVVNKYFEI | 22 | ||
DGGCLNASEVVVNN | 14 | ||
KARVYYESM | 9 | ||
LKYAIS | 6 | ||
TVAGVSILS | 9 | ||
GATCVIGTT | 9 | ||
LKTLYKDV | 8 | ||
YPKCDRA | 7 | ||
CRIFASLILARKHGTCCTT | 19 | ||
YRLANECAQVLSEYVLCGGGYYVKPG | 26 | ||
ANSVFNILQA | 10 | ||
TANVSAL | 7 | ||